Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,242,199,016
+$126,208,686 QoQ
Shares Held
4,891,125
+7.1% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#57
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $4,331,881,187 across 11 Drug Manufacturers - General names. JNJ ranks #1 (28.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
4,891,125 | $1,242,199,016 | |
| 2 | LLY |
ELI LILLY & Co
|
1,003,469 | $1,203,590,923 | |
| 3 | ABBV |
AbbVie Inc.
|
2,578,333 | $648,811,716 | |
| 4 | AZN |
Astrazeneca PLC
|
1,621,109 | $307,394,688 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,334,726 | $300,012,291 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,971,583 | $249,089,796 | |
| 7 | AMGN |
Amgen Inc
|
420,259 | $152,184,189 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,007,448 | $115,669,153 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,242,199,016 | 4,891,125 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,115,990,330 | 4,565,498 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $322,540,059 | 1,558,541 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $282,419,134 | 1,523,132 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $236,961,685 | 1,551,304 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $264,092,405 | 1,592,453 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $248,474,513 | 1,718,120 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $285,704,648 | 1,762,956 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $242,391,451 | 1,658,398 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $254,306,401 | 1,607,601 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $251,432,119 | 1,604,135 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $261,751,424 | 1,680,587 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $293,965,506 | 1,776,012 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $284,237,295 | 1,833,789 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $564,800,747 | 3,197,287 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $528,479,564 | 3,235,061 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $571,781,188 | 3,221,121 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $578,634,859 | 3,264,881 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $522,244,377 | 3,052,811 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $493,273,972 | 3,054,328 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $509,364,217 | 3,091,928 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $479,463,842 | 2,917,334 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $466,786,876 | 2,965,986 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $463,099,278 | 3,110,554 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $501,152,864 | 3,563,627 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $429,153,346 | 3,272,732 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||